Cingulate Inc.

6.27 USD
+1.78 (+39.64%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cingulate Inc. stock is down -17.5% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 2 December’s closed higher than November.

About Cingulate Inc.

Cingulate Inc. focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas with an additional location in Morristown, New Jersey.